RecruitingNCT06512493

South East (Zuid Oost) Netherlands Heart Registry

South East (Zuid Oost) Netherlands Heart Registry (ZON-HR)


Sponsor

Radboud University Medical Center

Enrollment

99,999 participants

Start Date

Nov 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Rationale: Patients undergoing percutaneous coronary intervention (PCI) for chronic coronary syndrome (CCS) or acute coronary syndrome (ACS) have a residual risk of ischemic events after PCI due to the progression of atherosclerosis in and outside the stented segments. The residual risk is affected by thrombotic, lipid, inflammation and diabetic risk factors. Secondary prevention after PCI is therefore of major importance to reduce complications and improve the patients' prognosis. Objective: To provide an extensive overview on the quality of secondary prevention and personalized medicine, a consortium in the South East Netherlands has created a PCI registry, the "Zuid Oost Nederland Hart Registratie" (ZON-HR).


Eligibility

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(4)

ZuyderlandMC

Heerlen, Limburg, Netherlands

MaastrichtUMC+

Maastricht, Limburg, Netherlands

VieCuri

Venlo, Limburg, Netherlands

Radboud University Medical Centre

Nijmegen, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06512493


Related Trials